APPENDIX A1.
Variable | N present | N missing | % missing |
---|---|---|---|
Days COVID-19 test sample to admission | 2031 | 0 | 0.0 |
| |||
Mortality | 2031 | 0 | 0.0 |
Province | 2031 | 0 | 0.0 |
Sex | 2030 | 1 | 0.0 |
| |||
Age | 2029 | 2 | 0.1 |
| |||
Days symptom onset to admission | 1743 | 288 | 14.2 |
| |||
Days symptom onset to COVID-19 test sample | 1743 | 288 | 14.2 |
| |||
ICU | 1647 | 384 | 18.9 |
| |||
Mechanical ventilation | 1643 | 388 | 19.1 |
| |||
LOS | 1640 | 391 | 19.3 |
| |||
Housing | 1633 | 398 | 19.6 |
| |||
Antibiotics or anti-virals | 1625 | 406 | 20.0 |
| |||
Direct acting antiviral or immunie modulatory medications | 1622 | 409 | 20.1 |
| |||
Clinical Frailty Scale | 1602 | 429 | 21.1 |
| |||
Cardiovascular | 1584 | 447 | 22.0 |
| |||
At least one comorbidity | 1583 | 448 | 22.1 |
| |||
Respiratory | 1583 | 448 | 22.1 |
| |||
Immunosuppressed | 1583 | 448 | 22.1 |
| |||
Immunocompromised | 1583 | 448 | 22.1 |
| |||
Goals of care | 1571 | 460 | 22.6 |
| |||
Travel history | 1463 | 568 | 28.0 |
| |||
Ethnicitya | 1419 | 612 | 30.1 |
| |||
Occupation | 1346 | 685 | 33.7 |
| |||
Known direct exposure | 810 | 1221 | 60.1 |
Research Ethics Board regulations did not allow collection of ethnicity data at some sites.